Study of Anlotinib in Patients With Gastric Cancer(ALTER0503)

The purpose of this study is to compare the effects and safety of Anlotinib with placebo in patients with Gastric Cancer.

Clinical Study Identifier: NCT02461407

Start Over

Nanjing, China

Nanjing, China

View all locations

Recruitment Status: Open

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.

Powered by